Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Onco-Innovations Limited (ONCO.NE)

Onco-Innovations Limited (ONCO.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 38,628
  • Shares Outstanding, K 59,428
  • Annual Sales, $ 65 K
  • Annual Income, $ -8,495 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 198.76
  • Price/Cash Flow N/A
  • Price/Book 99.35

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5000 +20.00%
on 03/27/26
0.7400 -18.92%
on 03/27/26
-0.0500 (-7.69%)
since 03/06/26
3-Month
0.5000 +20.00%
on 03/27/26
1.3100 -54.20%
on 01/08/26
-0.7100 (-54.20%)
since 01/07/26
52-Week
0.5000 +20.00%
on 03/27/26
2.3800 -74.79%
on 06/30/25
-0.9700 (-61.78%)
since 04/07/25

Most Recent Stories

More News
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI

MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade,...

ONCO.NE : 0.6000 (-7.69%)
ONNVF : 0.4086 (-17.04%)
ONMD : 0.9037 (-5.10%)
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms

VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Onco-Innovations Limited (CBOE CA: ONCO ) (OTCQB: ONNVF ) (Frankfurt: W1H , WKN: A3EKSZ ) (" Onco " or the " Company ”) is pleased...

ONCO.NE : 0.6000 (-7.69%)
ONNVF : 0.4086 (-17.04%)
ONMD : 0.9037 (-5.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Onco-Innovations Ltd is a pre-clinical stage biotechnology company working on developing drug candidates that can increase the effectiveness of current cancer treatments.

See More

Key Turning Points

3rd Resistance Point 0.7333
2nd Resistance Point 0.7167
1st Resistance Point 0.6833
Last Price 0.6000
1st Support Level 0.6333
2nd Support Level 0.6167
3rd Support Level 0.5833

See More

52-Week High 2.3800
Fibonacci 61.8% 1.6618
Fibonacci 50% 1.4400
Fibonacci 38.2% 1.2182
Last Price 0.6000
52-Week Low 0.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.